PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
PAVmed Inc. reported significant progress across its businesses, including Veris Health accelerating commercial engagement with OSU-The James and advancing its implantable physiological monitor towards FDA submission. Lucid Diagnostics secured its first laboratory benefit manager coverage policy for EsoGuard and recognized $1.5 million in revenue …